Vital Signs - Specialty Generics - Next Wave of Generics Growth
Vital Signs - Specialty Generics - Next Wave of Generics Growth
RELEASE DATE
02-Apr-2007
02-Apr-2007
REGION
North America
North America
Research Code: 9561-00-2D-00-00
SKU: HC00477-NA-MR_03949
$1,500.00
In stock
SKU
HC00477-NA-MR_03949
Description
This issue of Vital Signs, released on April 2, 2007, provides a strategic overview of the potential for specialty generics in the pharmaceutical industry. Additionally, an emerging company profile is provided for Abrika Pharmaceuticals, an emerging specialty generic pharmaceuticals company. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 19 - March 23, 2007.
Table of Contents
This week's issue:
Popular Topics
Top 10 Growth Opportunities for 2023
commercial aircraft market forecast
This issue of Vital Signs, released on April 2, 2007, provides a strategic overview of the potential for specialty generics in the pharmaceutical industry. Additionally, an emerging company profile is provided for Abrika Pharmaceuticals, an emerging specialty generic pharmaceuticals company. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of March 19 - March 23, 2007.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-2D-00-00 |
Is Prebook | No |